Free Trial

Crescent Capital BDC, Inc. (NASDAQ:CCAP) Sees Large Growth in Short Interest

Crescent Capital BDC logo with Finance background

Crescent Capital BDC, Inc. (NASDAQ:CCAP - Get Free Report) was the recipient of a large growth in short interest in March. As of March 31st, there was short interest totalling 139,400 shares, a growth of 26.3% from the March 15th total of 110,400 shares. Based on an average trading volume of 143,900 shares, the days-to-cover ratio is currently 1.0 days. Currently, 0.4% of the shares of the stock are short sold.

Institutional Trading of Crescent Capital BDC

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Montag A & Associates Inc. acquired a new stake in shares of Crescent Capital BDC in the fourth quarter worth approximately $35,000. C M Bidwell & Associates Ltd. purchased a new position in shares of Crescent Capital BDC in the 4th quarter valued at $39,000. Aquatic Capital Management LLC acquired a new position in shares of Crescent Capital BDC during the fourth quarter worth about $129,000. Generation Capital Management LLC acquired a new position in Crescent Capital BDC during the 4th quarter worth approximately $192,000. Finally, First Affirmative Financial Network acquired a new position in shares of Crescent Capital BDC during the first quarter worth $199,000. Hedge funds and other institutional investors own 49.46% of the company's stock.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on CCAP. Wells Fargo & Company reduced their price target on shares of Crescent Capital BDC from $19.00 to $18.00 and set an "equal weight" rating on the stock in a report on Friday, February 21st. Keefe, Bruyette & Woods reduced their target price on Crescent Capital BDC from $20.00 to $18.50 and set an "outperform" rating on the stock in a research note on Tuesday, April 8th. One analyst has rated the stock with a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $18.90.

View Our Latest Research Report on CCAP

Crescent Capital BDC Trading Up 2.6 %

Shares of NASDAQ CCAP traded up $0.40 during midday trading on Thursday, reaching $15.98. 98,006 shares of the stock were exchanged, compared to its average volume of 143,589. The company has a current ratio of 1.32, a quick ratio of 1.26 and a debt-to-equity ratio of 1.18. The company has a market capitalization of $592.25 million, a P/E ratio of 8.03 and a beta of 0.56. The stock has a 50 day moving average price of $16.95 and a 200-day moving average price of $18.35. Crescent Capital BDC has a 52-week low of $13.54 and a 52-week high of $20.19.

Crescent Capital BDC (NASDAQ:CCAP - Get Free Report) last released its earnings results on Wednesday, February 19th. The company reported $0.55 EPS for the quarter, missing the consensus estimate of $0.56 by ($0.01). Crescent Capital BDC had a return on equity of 11.90% and a net margin of 37.32%. The firm had revenue of $46.40 million during the quarter, compared to analysts' expectations of $47.27 million. Equities research analysts expect that Crescent Capital BDC will post 2.09 earnings per share for the current fiscal year.

Crescent Capital BDC Dividend Announcement

The firm also recently announced a dividend, which was paid on Friday, March 14th. Investors of record on Friday, February 28th were given a dividend of $0.05 per share. The ex-dividend date of this dividend was Friday, February 28th. Crescent Capital BDC's dividend payout ratio (DPR) is presently 84.42%.

Crescent Capital BDC Company Profile

(Get Free Report)

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.

Featured Stories

Should You Invest $1,000 in Crescent Capital BDC Right Now?

Before you consider Crescent Capital BDC, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Crescent Capital BDC wasn't on the list.

While Crescent Capital BDC currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Markets in Rally Mode: Will Earnings Keep It Going?
3 Tech Stocks to Buy Now—And 3 You’ll Regret Keeping
After Stellar Earnings, Is TSMC the Next Chip Leader?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines